Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marjorie Caro

Psychiatry Miami, FL Medical Doctor

NPI 1902811490 CMS profile 221618

5860 W Flagler St, Miami, FL 33144

Open in the dashboard

General payments

$4,679

237 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Marjorie Caro of Miami, FL is reported in the CMS Open Payments database as having received $4,679 across 237 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,237 40
2024 General $986 50
2023 General $1,009 56
2022 General $816 30
2021 General $87 5
2020 General $190 20
2019 General $355 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marjorie Caro
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Marjorie Caro were reported at $1,237. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Marjorie Caro Psychiatry median Middle half National median
2019 $355 $184 $59–$605 $163
2020 $190 $119 $36–$372 $114
2021 $87 $143 $43–$576 $132
2022 $816 $153 $50–$590 $149
2023 $1,009 $170 $56–$651 $160
2024 $986 $179 $57–$673 $164
2025 $1,237 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Teva Pharmaceuticals USA, Inc. $1,084 62 payments
  2. Otsuka America Pharmaceutical, Inc. $994 40 payments
  3. AbbVie, Inc. $761 42 payments
  4. Eisai Inc. $352 6 payments
  5. Lundbeck LLC $342 15 payments
  6. Allergan Inc. $310 42 payments
  7. ITI, Inc. $245 7 payments
  8. Alkermes, Inc. $110 6 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $88 1 payment
  10. Almatica Pharma LLC $75 4 payments
  11. Other $317 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,570 236 payments
  2. Education $109 1 payment
Products named General payments · program years 2019–2025
  1. VRAYLAR Neuroscience $761 42 payments
  2. Austedo XR $637 44 payments
  3. ABILIFY MAINTENA $577 23 payments
  4. ABILIFY ASIMTUFII $471 15 payments
  5. Leqembi $408 8 payments
  6. AUSTEDO $338 17 payments
  7. VRAYLAR Neuroscience $300 40 payments
  8. REXULTI Psychiatry $298 13 payments
  9. REXULTI Psychiatry $196 5 payments
  10. CAPLYTA $164 3 payments
  11. Other $1,197 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 57 drugs

Part D claims

16,643

Median for Psychiatry: 574

Drug cost

$508,753

Median for Psychiatry: $27,624

Branded share of claims

5.6%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Abilify Maintena Aripiprazole Brand 95 $206,427
Nuplazid Pimavanserin Tartrate Brand 11 $52,618
Aripiprazole Generic 320 $38,834
Quetiapine Fumarate Generic 2,360 $28,915
Mirtazapine Generic 1,300 $25,331
Rexulti Brexpiprazole Brand 16 $23,184
Quetiapine Fumarate Er Quetiapine Fumarate Brand 76 $15,567
Clonazepam Generic 1,813 $9,096
Bupropion Xl Bupropion Hcl Brand 155 $7,927
Escitalopram Oxalate Generic 1,505 $7,014

The 10 drugs with the highest cost, of 57 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$45,230

Medicare's payments for the services billed

Medicare patients

139

Average age 73

Services billed

445

103 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Depression 70%
Arthritis 45%
Diabetes 42%
Alzheimer's or dementia 26%
Ischemic heart disease 24%
Chronic kidney disease 24%
COPD 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
  • Lundbeck LLC $234
$234 16 —
ABILIFY ASIMTUFII
  • Otsuka America Pharmaceutical, Inc. $184
$184 — —
Leqembi
  • Eisai Inc. $147
  • Biogen, Inc. $26
$173 — —
Austedo XR
  • Teva Pharmaceuticals USA, Inc. $133
$133 — —
ABILIFY MAINTENA
  • Otsuka America Pharmaceutical, Inc. $121
$121 95 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

237 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record